- BD Intelligence - Any Disease - Global
Find the researchers and assets your pipeline needs — before your competitors do
OniX maps emerging investigators, assets, recent grants and applications, and therapeutic modalities across any disease area — scanning 25+ countries and 100+ funding bodies simultaneously. From oncology to rare disease, from NIH to JSPS.
5.0M+
Grants & Assets
100K+
Companies in network
20K+
Universities & Research organizations
500+
Funding Organizations
100+
Countries
Who we serve
Three distinct challenges,
one precision partner
Precision scouting of emerging researchers across any disease area — oncology, rare disease, CNS, cardiometabolic, and more. Any geography, any funder. MoA-tagged, BD-ready.
​
​
Navigate today's funding disruption. Build industry partnerships, diversify revenue, access international grants, and find alternative pathways through our PIVOT program.
​
​
Cross-species innovation intelligence. Human-to-animal and animal-to-human pipeline translation. Veterinary BD scouting and partnership development.
​
​
Case study — rare bone disease
Any disease. Any geography.
Proven
44+
Emerging researchers mapped across 15 countries — bone diseases alone. We do this for any therapeutic area.
9+
Funding bodies tracked simultaneously: NIH, UKRI, DFG, ANR, Telethon, JSPS/AMED, NHMRC, ZonMw & more
8+
Therapeutic modalities classified per researcher: GT, CRISPR, SM, peptide, mAb, ASO, cell therapy, biologic
"The researchers your BD team hasn't found yet — in any disease, anywhere."
Share your Innovation
For researchers, startups, and biotech innovators: Submit a non-confidential abstract of your therapeutic idea, asset, or product -​ here. Whether it's a funded project, grant application, or early-stage concept, our team wants to learn about your innovation.
-
An OniX expert will personally review your submission
-
We'll request additional information if needed to fully understand your opportunity
-
Based on our comprehensive database and network, we'll facilitate targeted introductions to potential partners aligned with your innovation